(Total Views: 141)
Posted On: 06/11/2018 8:57:15 AM
Post# of 40991
My projection - December/Jan timeframe:
Assumptions: Accelerating revenue; Final FINRA approval; share reduction to ~2.6B; assumes cash flow does improve.
Q-4 Revenue $3.0M - conservative - Annualized moving forward basis $12.0M.
Profit 33% - annualized based on Q-4 - $4M
P/E Ratio 30 times - $120M
$120M/2.6B shares = $.046/share.
My numbers are conservative and if Jeff gets one good private label contract, this number could double easily.
FINRA approval is critical.
Assumptions: Accelerating revenue; Final FINRA approval; share reduction to ~2.6B; assumes cash flow does improve.
Q-4 Revenue $3.0M - conservative - Annualized moving forward basis $12.0M.
Profit 33% - annualized based on Q-4 - $4M
P/E Ratio 30 times - $120M
$120M/2.6B shares = $.046/share.
My numbers are conservative and if Jeff gets one good private label contract, this number could double easily.
FINRA approval is critical.
(0)
(0)
